Sarclisa Escena
NDC 0024-0674, isatuximab-irfc, injection, solution, from Sanofi-Aventis U.S. LLC.
- Product NDC
- 0024-0674
- Status
- Listed
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761445
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0024-0674 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ISATUXIMAB140 mg/mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0024-0674-01 | 00024067401 | 1 VIAL in 1 CARTON (0024-0674-01) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/07730e8c-1340-4d30-8d71-e20f850db8da
Use it
Look up 0024-0674 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0024-0674 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0024-0674. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.